A Randomized Controlled Trial Evaluating Virologic and Renal Outcomes After Switching from TDF+FTC or 3TC+EFV to TDF/3TC/DTG (TLD) Versus DTG+3TC in Virologically Suppressed Thai PWH – A Pilot Study
Dual therapy with DTG + 3TC may be a preferable switch option over TLD for virologically suppressed PWH with renal safety concerns.
Authors
- Opass Putcharoen (ORCID: https://orcid.org/0000-0001-8444-8512)
- Samadhi Patamatamkul (ORCID: https://orcid.org/0000-0002-6350-9758)
- Sathaporn Kanogtorn
Institutions
- Mahasarakham University (TH)
- Thai Red Cross Society (TH)
- Chulalongkorn University (TH)
Publication Details
- Journal
- Current HIV Research
- Published
- 2025-09-29
- DOI
- https://doi.org/10.2174/011570162x384022250910065252
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00